We understand the unique challenges life science companies face in securing funding, licensing and safeguarding intellectual property, establishing partnerships, bringing new products to market, opening new revenue streams, and protecting existing product lines. GlaxoSmithKline, Katie Reuther, Ph.D, MBA CSL Behring, Kathleen Shay (Secretary) Estimated $95.7K - $121K a year. In a prepared statement, Goodwin Chairman Rob Insoliasaid that the firms strategy is to be the firm of choice for clients doing business within the healthcare, life sciences, private equity, real estate, technology, and financial services sectors, and where they converge. * Denotes experience prior to joining Goodwin. He joined the firm in 2023. Life Sciences Pennsylvania, Maureen L. Mulvihill, Ph.D. President & CEO Partner Click here to login, 2023, Portfolio Media, Inc. | About | Contact Us | Legal Jobs | Advertise with Law360 | Careers at Law360 | Terms | Privacy Policy | Cookie Settings | Help | Site Map | Resource Library | Law360 Company, Enter your details below and select your area(s) of interest to stay ahead of the curve and receive Law360's daily newsletters, Email (NOTE: Free email domains not supported). Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology. However, it emerged earlier this month that the firm has embarked on a round of job cuts in response to the economic slowdown that affects associates, paralegals and business professionals across multiple US offices. We take a multidisciplinary approach to address clients challenges, drawing on our deep expertise across industries such as technology, healthcare, real estate, and private equity as well as the full spectrum of relevant practices. Philadelphia 'Heavy Hitters' Exit Troutman Pepper, Casting WebGoodwin Procter LLP has expanded its transactional team with the addition of a private equity partner who joined the firm's Washington, D.C., office working remotely from Philadelphia. While Goodwin Procters arrival into the Philadelphia legal marketplace may slightly raise the competitive pressures on homegrown law firms, leaders in the city With Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Goodwin Procter is conducting stealth layoffs Goodwin Procter Chief Legal Officer After confirming the addition of a 14-partner group from Troutman Pepper Hamilton Sanders last week, leaders at Goodwin Procter said they have a 12-month Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. A Troutman Pepper spokesperson confirmed the lawyers' departures, adding: We appreciate their contributions to the firm and wish them well in their future endeavours.. He has significant experience handling regulatory issues arising under fraud and abuse laws (including the federal Anti-Kickback Statute), Stark, civil monetary penalties law, False Claims Act, health care fraud statutes, HIPAA and privacy and security, reimbursement, state laws, including CPOM, fee splitting, licensing, credentialing and state Board issues and mini anti-referral and anti-fraud and abuse laws and other laws that impact health care clients and M&A transactions. WebGreater Philadelphia. WebOur globally recognized Life Sciences practice is uniquely positioned to partner with innovators and investors operating in a fast-moving, tech-driven environment.. With more than 230 dedicated lawyers across all major life sciences hubs in the US, Europe, and Asia, we work with life sciences companies throughout the corporate lifecycle from startup New arrivals land mostly in US giants newly-official Philadelphia base to bolster life sciences, healthcare private equity and white collar practices. In addition, she advises clients on a variety of corporate governance and securities law matters. ), Create custom alerts for specific article and case topics and, I took a free trial but didn't get a verification email. Vice President Sales & Marketing, Gastroenterology Luxury Law is a comprehensive guide providing answers and insight into how luxury businesses can protect their brands in a range of jurisdictions. Goodwin Procter Stephanie A. Dyson Vice President U.S. Policy & Government Affairs Bristol Myers Squibb Company. Chambers USA, for example, recognizes the firm in 75 areas across eight different regions, with 17 of those accolades positioning the firm at the very top of its field.Talking numbers, Goodwins revenue more than doubled to over $1.5 billion US Head Vaccine Public Affairs and Advocacy Law firm Goodwin hires 14-partner Troutman Pepper group, Law firm Goodwin Procter cuts lawyers and staff amid shrinking demand. Legal. Goodwin Procter - Wikipedia He is a former member of the adjunct faculty at Drexel University Kline School of Law and established and taught the Health Law Practicum in the Health Law Concentration to upper-level students. Abe Kwon | LinkedIn Aviation lawyer Denny Shupe leads five-lawyer group departing Boston-based Goodwin Procter, which announced dozens of layoffs earlier this month, is reportedly opening a Philadelphia office with 17 health-care transactions Senior Vice President President & CEO Chairman, President & CEO Our Standards: The Thomson Reuters Trust Principles. +1 445 207 7805. Goodwin Procter is laying off associates, paralegals, and other professional staff across its offices amid a slowdown in legal work following historic demand a year earlier. Please see our Privacy Policy. And I dont think theyre going to say yes.. D. Arthur Magaziner Human Services Award See here for a complete list of exchanges and delays. Web46 Philadelphia Ms jobs available in California on Indeed.com. The industry leader for online information for tax, accounting and finance professionals. Thanks to Elevated Angles LLC for John also handles the full range of traditional health care and managed care and payor issues such as hospital-physician relations, nonprofit and reserved power issues, attorney general and orphans court issues and procedures, certificates of need and licensure, patient rights issues, including care access and delivery issues and reimbursement and payor issues. She also represents life sciences companies in private placements, venture capital, and other capital-raising transactions. The earlier hires included Rachael Bushey, who was chair of Troutman Pepper's health sciences department, and John Jones, who served as chair of the health care transactions and regulatory practices. Feb 2022 - Present1 year 5 months. The office also focuses on representing the largest financial institutions and leading FinTech companies with their litigation, enforcement, regulatory, and supervisory needs. It marks a significant expansion for Goodwin in the city, where it has had a presence since early 2022 when private equity partner Barbara Shander joined from pharmaceutical company WCG along with a team of associates. WebPhiladelphia, Pennsylvania, United States. Led a team of student managers in a fast paced environment. President, CEO and Board Member 820 followers 500+ connections. The group will be joined by partner Barbara Shander, a transactional lawyer focused on Private Equitydeals who has been working remotely from Philadelphia since joining Goodwin last February. Recent financial growth under chairman David Hashmall has put Goodwin Procter at the top in the tech and capital arena. P&G has teamed up with Microsoft to pilot innovations in cloud, AI, and digital transformation across its diaper and paper towel manufacturing units. This post is based on their Goodwin Procter memorandum. Monroe E. Trout Law and Medicine Award Allison, Alicia, Justin and Laura, together with our existing team, extend their expertise and the depth of Goodwins global platform to this vibrant market.. Goodwin WebI am an associate at Goodwin Procter LLP, and an alumnus of NYU School of Law, Villanova University School of Law and Drexel University's LeBow College of Business. WebAccording to the National Law Journal's 2023 NLJ 500 ranking of firms based on size, Goodwin has 1633 attorneys and is ranked 17th in the United States. The group is led by Thomas Gallagher, Rachael Busheyand John Jones three of the biggest rainmakers in Philadelphia. By James Boyle (March 1, 2022, 3:36 PM EST) -- Goodwin Procter LLP has expanded its transactional team with the addition of a private equity partner who joined the firm's Washington, D.C., office working remotely from Philadelphia. Access to case data within articles (numbers, filings, courts, nature of suit, and more. Goodwin is uniquely positioned to serve clients at the busy intersection of capital and innovation. Jennifer Porter Life Sciences Partner at Goodwin Procter Philadelphia, PA. Asher Funk Partner at Goodwin | Healthcare Private Equity Greater Chicago Area. Providers and suppliers rely on John to interface with some of the top managed care companies and PBMs on some of the most transformative and challenging payment issues including, value-based care and risk share arrangements. Retired CEO and former Chairman Wake Up Call: Goodwin Poaches 17 Troutman Health-Care Partners Philadelphia. This was a fun one to produce and edit. WebLiked by Jonathan Ishee, JD, MPH, MS, LLM, CIPP/US. Bill Weiss, a partner in Goodwin's Tax practice, advises U.S. and international clients on the tax aspects of corporate and partnership transactions, including tax-free reorganizations, spinoffs, leveraged buyouts, restructurings, equity-based compensation arrangements and the formation of joint ventures. There is more to the comparison, and in the sections below, we discuss why we believe EL stock will offer better returns than PG stock in the next three years. Life Sciences Partner at Goodwin Procter Philadelphia, PA. Daniel Scolnick, Ph.D., Esq. Connect with our Life Sciences team and let us know how we can help. He represents issuers and underwriters in a variety of corporate finance transactions, including initial public offerings and other public and private offerings of debt, equity, and preferred securities. Board of Directors The law firm represented Nicklin, Platt and Umbrecht do corporate work for life sciences, biotechnology and pharmaceutical clients while Palladino focuses on patent prosecution, Goodwin said. Goodwin Procter, Barbara Carlin, CPA, MBA First, the usual boilerplate: Goodwin clocked in at No. Philadelphia Hannah Roberts. Global corporates are playing a vital role in the fight to curb plastic pollution by stepping up to drive action to innovate new ways to combat waste. He joined the firm in 2023. 1996). Your experience on this site will be improved by allowing cookies. Susan Dillon, Ph.D. President & CEO Aro Biotherapeutics. Goodwins appellate practice, which is anchored in the Washington, DC office, is nationally recognized and boasts several US Supreme Court wins in recent years. The four lawyers joining Goodwin on Wednesday were each promoted to partner at Troutman Pepper in January, according to an announcement at the time. Goodwin Officially Enters Philadelphia with 14 Partners Across 3 Practice Groups (Philadelphia Business Journal). We are in the business of building authentic, long-term relationships with our clients, who are some of the worlds most successful and innovative investors, entrepreneurs and disruptors in the life sciences, private equity, real estate, Technology Transfer, Innovation and Research Contracts Partner Cooley Alert: Will SCOTUS affirmative action decision affect your companys DEI policies? WebJennifer has years of experience counseling clients in the life sciences industry through their most important strategic transactions and disclosure and governance issues. Damian Lillard and the Portland Trail Blazers appear to be at a stalemate. Philadelphia lawyer elected chair of Troutman Pepper Top 20 US firm Goodwin Procter has secured a group of 14 partners from Troutman Pepper to officially launch in Philadelphia. Goodwin Continues Expansion in Philadelphia and New Excellence for the Future, State Securities Regulation Award), Co-Leader Healthcare Private Equity Practice, Representative Healthcare Private Equity and Strategic Transactions, Healthcare Private Equity, Strategic Transactions and Regulatory, Privacy, Security, and Information Technology, Health Care M&A Activity Remains Immune to COVID-19, $3.1 billion sale of a national assisted living company*, $1 billion sale of a national long-term care pharmacy chain to a private equity sponsor*, $1 billion+ sale of a group purchasing organization*, $750 million+ equity investment in an outpatient pharmacy management company*, $500 million+ acquisition of an inpatient pharmacy management company*, Sale of cannabis company to multinational public cannabis company*, $500 million+ merger of national oncology groups*, $300 million+ acquisition and consolidation of staffing company*, $500 million+ acquisition of a national pharmacy*, $500 million+ recapitalization of specialty and LTC pharmacies*, $500 million+ sale of medical device company to a financial sponsor*, $400 million+ financial sponsor investment in a PBM*, $500 million+ financial sponsor acquisition of veterinary practices and roll-up*, $250 million+ group purchasing organization roll-ups**, Several complex, $1billion+ REIT, skilled nursing facility and ALF acquisitions in Texas and Louisiana*, $200 million+ acquisition of specialty pharmacy by a financial sponsor*, $100 million+ financial sponsor acquisition of home care company and subsequent roll-up*, $100 million+ physical therapy acquisition and roll-ups*, $100 million+ sale of specialty pharmacy to a financial sponsor*, $150 million+ sale of behavioral health pharmacy to a financial sponsor*, $100 million+ sale of childrens dental platform to financial sponsor*, $100 million+ acquisition of retail pharmacy chain by a strategic*, $50 million+ sale of revenue cycle management company to financial sponsor*, Multi-million dollar health system physician roll-ups*, Cleveland Clinics formation of the first clinically based GPO*, Cancer hospital disposition of cancer center*, Complex supply chain and GPO strategic transaction for Walgreens*, Senior Care Centers (TX) in several complex, $100 million+ strategic transactions in the skilled nursing facility and post-acute care space, including pharmacy and home health*, $100 million+ sale of a urology practice management company*, $125 million+ sale of a rehabilitation provider*, Private equity sponsors investment in a radiology services company*, $100 million+ acquisition of ambulance services company*, Multiple physician joint ventures with a national dialysis provider*, $100 million+ sale of dental practice management company*, $150 million+ consolidation and sale of OB/GYN practice management company*, $100 million+ merger of national pharmacies*, $25 million+ acquisition of telepharmacy/health company by a financial sponsor*, Complex specialty pharma and supply chain transaction for Novartis*, Significant national and regional health systems affiliations and dispositions*, Supply chain, GPO and PSAO transactions for AmerisourceBergen*, Advised physician groups (including orthopedics, dermatology, behavioral health, dental, radiology, urology, podiatry, primary care, oncology, emergency medicine, gastroenterology, fertility, womens health, dialysis, nursing, veterinary, ophthalmology, pain management, and ENT) in several $100 million+ physician practice management deals with financial sponsors and strategics*, Complex supply chain transaction for Mayo Clinic*, Several $50 million+ provider/supplier acquisitions and dispositions*, Formation of national GPO among 5 health systems*, Affiliation between largest national childrens hospital GPO and national GPO*, Counseled senior care, personal care, CCRCs, independent living, ALFs and group homes on strategic transactions and regulatory matters*, Counseling largest national outpatient pharmacy management company on equity investment by Welsh Carson and Walgreen Co.*, Counseling one of the largest institutional pharmacies on sale transaction*, Counseling financial sponsors and strategic investors on mergers, acquisitions and dispositions and complex federal and state health care regulatory issues impacting M&A transactions*, Counseling private equity sponsor in connection with acquisition of Comprehensive Pharmacy Services*, Counseling private equity fund regarding exit strategies and disposition of equity interest in managed care organization joint venture*, Counseling private equity fund on health care regulatory issues impacting disposition of equity interest in group purchasing organization*, Counseling private equity fund on health care regulatory issues impacting acquisition of third-party administrator and underwriting and claims services company add-on*, Establishing buy-sell arrangements for various corporations and partnerships and other strategics, including all participants in the medical and pharmaceutical supply chain*, Counseling Summit Health in its combination with WellSpan*, Counseling hospitals on affiliations, acquisitions, and dispositions, including the affiliation of Hanover Healthcare PLUS, a community health care network in central Pennsylvania that includes the 93-bed Hanover Hospital, in its affiliation with UPMC Pinnacle, the largest health system in the state*, Counseling national and regional health systems, physician groups, long-term care facilities, and other providers on regulatory matters, including fraud and abuse, Stark, facility licensure and operations, reimbursement, including Medicare and Medicaid payment, managed care contracting, physician credentialing and termination, and contract issues, including exclusive contracts*, Counseling medical device manufacturer of health care regulatory issues in connection with initial public offering*, Counseling physician and non-physician investors in multispecialty ASC private placement*, Advising health care staffing company regarding structure, formation and contractual issues, as well as health care regulatory and malpractice matters*, Counseling second largest dialysis provider in the world on payment and reimbursement issues under government and commercial payment programs*, Advising physician groups in establishing independent physician association, hospital-physician joint ventures, provider networks, multiservice organizations, and ancillary service corporations*, Counseling pharmaceutical manufacturers regarding fraud and abuse issues, including those presented under sales and marketing arrangements, consulting agreements, and arrangements with health care professionals*, Advising ASCs, specialty hospitals and outpatient diagnostic centers on regulatory compliance issues under federal and state fraud and abuse laws (including the federal Anti-Kickback Statute), anti-referral laws (including Stark), licensure and securities laws arising from physician and non-physician, including hospital, ownership of these centers and related real estate acquired through a private offering of partnership interests*, Advising product developer on health care regulatory issues through acquisition, private placement, public offering, and commercialization matters*, Counseling suppliers and vendors in connection with fraud and abuse and health care regulatory issues impacting their businesses and arrangements with other health care organizations and individual providers*, Advising hospitals and other health care organizations in connection with establishing and/or joining group purchasing organizations*, Advising public medical transcription services company on health care regulatory issues impacting its business, including issues under the federal Anti-Kickback Statute and civil monetary penalties law*, Counseling rehabilitation center on formation and structural issues and state and federal health care regulations, including fraud and abuse, anti-referral laws, professional licensure regulations, and fee splitting statutes*, Representing hospitals and health systems in connection with managed care payment issues, standard of care, and utilization review procedures*, Assisting health systems, physicians and other providers in formulating and executing managed care business strategies, purchase and sale of physician practices, formation and operation of ancillary joint ventures, and mergers and acquisitions*, Advising lenders in connection with certain health care regulatory issues (including Stark, fraud and abuse, and HIPAA) impacting acquisitions and joint ventures*, Counseling largest long-term care pharmacy GPO on fraud and abuse issues, safe harbor regulations, and regulatory issues impacting its relationships with other members in the medical supply chain, including manufacturers, suppliers, and pharmacies*, Advising Medicare Part D pharmacy network manager on rebate, discount and PDP issues under Medicare Prescription Drug, Improvement, and Modernization Act of 2003*, Counseling multispecialty physician group on development of specialty hospital and private placement*, Counseling national retail and long-term care pharmacy chain regarding state and federal health care regulatory issues impacting its business and negotiate and draft agreements with vendors and suppliers*, Counseling private multisite radiology practice on federal and state fraud and abuse, Stark, fee splitting, licensure and government and private payor reimbursement issues*, Advising providers, including hospitals, physician groups, and medical device companies on billing and claims issues, draft corporate compliance programs and procedures, and assist with implementing plan and monitoring compliance*, Advising manufacturers, medical device companies, physician practice groups, hospitals, and other providers and suppliers on the federal Anti-Kickback Statute and Stark (and safe harbors) in connection with marketing programs, physician recruitment deals and discount, and rebate arrangements*, Counseling nonprofit hospital on disposition of its equity interest in cancer center*, Structuring strategic alliances, partnering arrangements and collaborations both in traditional health care and life sciences space*, Advising startups and emerging health care businesses on corporate formation, structure, governance and compliance issues*, Advising specialty multi physician groups on fraud and abuse and marketing guidelines, including structuring plans and programs under civil monetary penalties law and federal Anti-Kickback Statute*, Counseling biotech and manufacturers in life sciences space on wholesale distribution and GPO contracting*, Counseling biotechnology companies on strategic alliances and partnering arrangements with big pharma*, Counseling academic institutions, research organizations and biotechnology companies on clinical research issues*, Counseling research sponsors in connection with clinical trials, research and development procedures, and compliance with FDA and HIPAA regulations*, Drafting clinical trial documents and agreements, including master services agreements, clinical study agreements, protocols, agreements with CROs, confidentiality agreements, informed consent, and authorization forms*, Counseling emerging life science business on raising funds in private placement and additional rounds of financing*, Advising research organizations on indemnification, regulatory compliance, and safe harbor issues under fraud and abuse and anti-referral laws*, Advising physician network on data use rights and monetization with pharma manufacturers*, Advising health care systems, providers and vendors in connection with interpretation and implementation of HIPAA privacy, security and transaction and code set regulations, including development of privacy policies, notices, authorizations, and business associate and data use agreements*, Assisting software vendors in structuring and developing tools for transactions and claims processing and electronically exchanging protected health information in compliance with HIPAA and development of direct data entry systems*, Assisting in structuring and developing of systems (including debit card payment systems) for health care payment incompliance with HIPAA*, Counseling hospitals and health systems, providers and suppliers on e-commerce issues, including health care regulatory issues (such as fraud and abuse) impacting web-site development and hosting arrangements*, Advising parties concerning complex commercial transactions involving research and development, product launch, and product life cycle*, Advising vendors on development and commercialization of technology innovations, including disease management, charity care, prescription drug plan, and electronic health records tools*, Structuring business process outsourcing transactions, including accounting, billing, and practice management*, Advising software vendors on HIPAA and state law privacy and confidentiality compliance issues impacting electronic health records and the nuances presented by HIV/AIDS, mental health, and drug and alcohol records*, Assisting CROs and product and device manufacturers in development of protocols, research, and investigator agreements and informed consent and authorizations in compliance with HIPAA*, Counseling educational institutions regarding obligations under HIPAA privacy regulations*, Advising health care systems on privacy and security aspects of computer systems, networks, and data, including HIPAA review and drafting policies and procedures in connection with use of technology*, U.S. District Court for the Middle District of Pennsylvania, Best of the Bar, Philadelphia Business Journal, 2021, Health Care M&A Lawyer of the Year, America M&A Atlas Awards, 2019, USA Private Equity Deal of the Year, 2019, Listed in Chambers USA: Americas Leading Lawyers for Business/Private Equity-Healthcare, Speaker, Long-Term Care Pharmacy Services to At-Home LTC Patients, ASHP 2022 Midyear Clinical Meeting & Exhibition, December 7, 2022, Speaker, Mergers and Acquisitions and the Regulatory Landscape in the Post-Acute Provider Space, Premier Continuum 2022 National Meeting, November 14, 2022, Speaker, Long-Term Care Pharmacy Services to At-Home LTC Patients, American Society of Consultant Pharmacists (ASCP) 2022 Annual Meeting & Exhibition, November 5, 2022, Panelist, Lets Make a Deal: Ensuring a Smooth Transaction, National Association of Specialty Pharmacy (NASP) Annual Meeting and Expo, September 19, 2022, Speaker, Where Are the Best Healthcare Deals Today?, ACG NY Healthcare Conference, June 22, 2022, Moderator, Long Term M&A Mindset: Buy, Sell or Exit? LTC 100 Leadership Conference 2022, May 24, 2022, Panelist, Healthcare: Specialty Practices, USA Growth & Deals, 4th Annual Forum, May 4, 2022, Panelist, Healthcare M&A, 13th Annual Americas M&A Atlas Growth & Deals Forum, January 26, 2022, Speaker, Strategies and Legal Issues Concerning Senior Living and Post-Acute Mergers and Acquisitions, Oregon Health Care Association (OHCA) Annual Convention, November 10, 2021, Moderator, Hospital & Other Providers Roundtable, 13th Annual Investment and M&A Opportunities in Healthcare Conference, September 20, 2021, Panelist, State of the Healthcare M&A Industry, 13th Annual Investment and M&A Opportunities in Healthcare Conference, September 20, 2021, Panelist, Smartest M&A and Development Strategies in the COVID SNF Bust, LTC 100 Leadership Conference, May 9-12, 2021, Speaker, Deals Outlook: Healthcare Trends, Global M&A Network: USA Growth & Deals Annual Intelligence Forum, May 25-26, 2021, Moderator, Track 2: Investors Panel: Where are investors placing their bets? ACG New York 13th Annual Healthcare Conference, February 25-26, 2021, Speaker, Compliance Issues Facing Hospital-Based Specialty Pharmacies, American Society of Health-System Pharmacists (ASHP) Midyear 2020 Clinical Meeting and Exposition, December 6-10, 2020, Speaker, Sector Review: Healthcare M&A, Americas Growth and Deals Forum, November 16, 2020, Speaker, Specialty Pharmacy Services to At-Home Patients, NASP 5th Annual Specialty Law Conference, September 14, 2020, Speaker, The Oregon Health Care Association Board of Directors Retreat, July 15, 2020, Conference Planner, ACG 12th Annual Healthcare Conference, February 27, 2020, Speaker, Private Equity: Deals, Strategists and Value Creation, Global M&A Networks Americas Growth and Deals 11th Intelligence Forum, October 24, 2019, Speaker, Compliance Issues Facing Hospital-Based Specialty Pharmacies, NASP Fourth Annual Specialty Pharmacy Law Conference, September 12, 2019, Presenter, Current State of the DSO Market, Webinar Co-hosted by Provident Healthcare Partners and Pepper Hamilton, April 25, 2019, Speaker, Stark Law and the Anti-Kickback Statute: Challenges, Pitfalls and Safe Harbors, The Knowledge Group Webcast, April 2, 2019, Co-Author, Protecting Your Company From Increased Scrutiny After Release of ARCOS Opioid Data, Pepper Hamilton Client Alert, August 22, 2019.
William Carey Outlook, Articles G